Connect with us

Technology

Syngene launches platform for rapid, enhanced protein production

Published

on

The new proprietary cell line development platform combines a robust cell line, transposon technology with high throughput clone screening and single cell imaging to deliver highly efficient protein production, with high titers, offering speed at reduced risk.

SAN DIEGO, June 4, 2024 /PRNewswire/ — Syngene International Ltd. (NSE: SYNGENE), a leading global contract research, development and manufacturing organization (CRDMO), announces the launch of its new protein production platform. The platform, using a cell line and transposon-based technology in-licensed from Swiss biotech services company, ExcellGene, coupled with Syngene’s clone selection and development processes, promises significant improvement in efficiency and precision.

The new platform accelerates enhanced protein production, enabling quicker preclinical and clinical development as well as product launches, thereby reducing time to market.  

“By combining the cell line and transposon-based platform from ExcellGene with our proprietary processes, we are pushing the boundaries in cell line development. This innovative approach will not only accelerate development timelines but also enhance the overall reliability and efficiency of the process, delivering substantial benefits to our clients,” said Sridevi Khambhampaty, Vice President, Biopharmaceutical Development, Syngene International.

“Syngene sees biologics as a key driver of future growth and we are committed to investing in cutting-edge technology to achieve reliability, precision and speed for clients.  By combining Syngene’s skills and experience with ExcellGene’s best-in-class cell line development technology, we can expedite getting molecules to market for the people and patients who need them,” said Alex Del Priore, Senior Vice President, Manufacturing Services, Syngene International.

“High yield manufacturing is a multifactorial exercise that starts with transfections and an optimised cell host. We are obviously delighted to partner with and to contribute to Syngene’s process development and manufacturing capabilities. This will leverage our technology and our cells (CHOExpress®) for the benefit of their extensive client base. At ExcellGene, we pride ourselves in having studied the profound challenges in DNA transfer to cultivated cells for decades and linked insights from such studies to their phenotypes and use in manufacturing. We are delighted that our work, combined with the talent and expertise of the Syngene team, will directly benefit patients around the world”, said Maria J. and Florian M. Wurm, Cofounders and Managers, ExcellGene 

The new platform streamlines clone selection and enhances operational productivity. It also supports a wide range of biomolecules including monoclonal antibodies, biosimilars, bispecifics, antibody-drug conjugates and other recombinant proteins. This versatility facilitates integration with both perfusion and fed-batch manufacturing processes. A track record in developing multiple monoclonal antibodies with the new technology underscores its effectiveness and reinforces Syngene’s ability to provide innovative solutions for its clients. By combining this technology with Syngene’s existing capabilities, the Company now offers a full range of end-to-end cell line development options, using the latest technology to deliver tangible benefits to customers.

About Syngene International Ltd.
Syngene International Ltd. (BSE: 539268, NSE: SYNGENE, ISIN: INE398R01022) is an integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors. Syngene’s more than 6000 scientists offer both skills and the capacity to deliver great science, robust data security, and quality manufacturing, at speed, to improve time-to-market and lower the cost of innovation. With a combination of dedicated research facilities for Amgen, Baxter, and Bristol-Myers Squibb as well as 2 Mn sq. ft of specialist discovery, development and manufacturing facilities, Syngene works with biotech companies pursuing leading-edge science as well as multinationals, including GSK, Zoetis and Merck KGaA. For more details, visit www.syngeneintl.com. For the Company’s latest Environmental, Social, and Governance (ESG)report, visit https://esgreport.syngeneintl.com/.

About ExcellGene SA (and ExcellGene Inc. USA) EXCELLGENE SA, located within the beautiful alps of Switzerland, has been leader in cell line generation, cell line development and high yielding manufacturing processes since 2001. It has served hundreds of customers, including some of the largest Pharma and Biotech companies. The company, family-managed and owned, has been at the forefront of cell culture-based technologies for protein production since inception. The more than 300 co-worker publications with >200 citations of these already in 2024 provide evidence of the scientific and technological excellence of the company. For more details, visit www.excellgene.com.

View original content:https://www.prnewswire.co.uk/news-releases/syngene-launches-platform-for-rapid-enhanced-protein-production-302164027.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

MINTO APARTMENT REIT ANNOUNCES NOVEMBER 2024 CASH DISTRIBUTION

Published

on

By

̶  Amount represents a 3% increase from previous level  ̶

OTTAWA, ON, Nov. 15, 2024 /CNW/ – Minto Apartment Real Estate Investment Trust (the “REIT”) (TSX: MI.UN) today announced a cash distribution of $0.04333 per REIT unit for the month of November 2024. Payment will be made on December 16, 2024 to unitholders of record as at November 30, 2024.

As previously announced, the amount of the November distribution represents a 3% increase from the prior level, resulting in an increase in the annualized amount of the REIT’s distribution from $0.505 per unit to $0.52 per unit.

About Minto Apartment Real Estate Investment Trust

Minto Apartment Real Estate Investment Trust is an unincorporated, open-ended real estate investment trust established pursuant to a declaration of trust under the laws of the Province of Ontario to own income-producing multi-residential properties located in urban markets in Canada. The REIT owns a portfolio of high-quality income-producing multi-residential rental properties located in Toronto, Montreal, Ottawa and Calgary. For more information on Minto Apartment REIT, please visit the REIT’s website at: https://www.mintoapartmentreit.com.

Forward-Looking Statements

This news release may contain forward-looking statements (within the meaning of applicable securities laws) relating to the business of the REIT. Forward-looking statements are identified by words such as “believe”, “anticipate”, “project”, “expect”, “intend”, “plan”, “will”, “may”, “estimate” and other similar expressions. These statements are based on the REIT’s expectations, estimates, forecasts and projections and include, without limitation, statements regarding the intended monthly distributions of the REIT. The forward-looking statements in this news release are based on certain assumptions, including without limitation that the REIT will have sufficient cash to pay its distributions. They are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. A number of factors could cause actual results to differ materially from the results discussed in the forward-looking statements, including, but not limited to, the factors discussed and referenced under the heading “Risks and Uncertainties” in the REIT’s Q3 2024 management’s discussion and analysis dated November 12, 2024, which is available at www.sedarplus.ca. There can be no assurance that forward-looking statements will prove to be accurate as actual outcomes and results may differ materially from those expressed in these forward-looking statements. Readers, therefore, should not place undue reliance on any such forward-looking statements. Further, these forward-looking statements are made as of the date of this news release and, except as expressly required by applicable law, the REIT assumes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

SOURCE Minto Apartment Real Estate Investment Trust

Continue Reading

Technology

Equinox, Inc. Provides Notification of Cybersecurity Incident

Published

on

By

ALBANY, N.Y., Nov. 15, 2024 /PRNewswire/ — Equinox, Inc. (“Equinox”), a nonprofit provider of various counseling and health services, has learned of a cybersecurity incident that involved the personal and / or protected health information belonging to certain current and former clients, and to a number of staff. On November 15, 2024, Equinox formally notified potentially affected individuals with available address information and provided resources to assist them.

On April 29, 2024, Equinox discovered unusual activity within its digital environment. Upon discovering this activity, Equinox immediately took steps to secure its systems and enlisted independent cybersecurity forensic experts to conduct an investigation. During this time, Equinox was vigilant and able to safely minimize any disruptions to its daily operations and service delivery.

As a result of an independent forensic investigation into the incident, Equinox learned that an unauthorized actor accessed and potentially acquired certain files stored within its internal systems. Following a comprehensive review of the potentially affected data, on September 16, 2024, Equinox determined that certain employee and client information may have been subject to the unauthorized access. This information varies between individuals, but may have included names, addresses, dates of birth, Social Security numbers, passport numbers, financial account information, driver’s license and/or state identification number, medical treatment or diagnosis information, health insurance information, and/or medication-related information.

Equinox has no evidence that any of the information potentially impacted in connection with this incident has been misused. Nonetheless, Equinox has implemented additional security features to help prevent similar incidents from occurring in the future. Equinox has also reported this matter to the NYS Attorney General, NYS Division of State Police, NYS Department of State’s Division of Consumer Protection, and the Federal Office of Civil Rights.

Notification letters were mailed to impacted individuals on November 15, 2024. The letters include information about this incident and about steps that potentially impacted individuals can take to monitor and help protect their personal and protected health information. Equinox has established a toll-free call center to answer questions about the incident and to address related concerns. The call center can be reached at (866) 531-3185, Monday through Friday from 9:00 AM to 9:00 PM Eastern time.

The privacy and protection of its clients and staff and their private information is a top priority of Equinox. Equinox deeply regrets any inconvenience or concern this incident may cause.

Equinox, Inc. is a human services agency with deep roots in the Capital Region dating back to 1947. Equinox provides compassionate services and life-enhancing opportunities to youth and adults—and their families—who are impacted by domestic violence, substance use and addictions, mental health disorders, homelessness, and the challenges of living amid poverty and violence.

View original content:https://www.prnewswire.com/news-releases/equinox-inc-provides-notification-of-cybersecurity-incident-302307303.html

SOURCE Equinox, Inc.

Continue Reading

Technology

Greenberg Traurig Helps United Way Worldwide Launch Star-Studded Hurricane Relief Benefit

Published

on

By

Global law firm Greenberg Traurig, LLP provided a variety of legal support to United Way Worldwide in support of its Benefit for Hurricane Relief.

WASHINGTON, Nov. 15, 2024 /PRNewswire-PRWeb/ — Global law firm Greenberg Traurig, LLP provided a variety of legal support to United Way Worldwide in support of its Benefit for Hurricane Relief.

The one-hour special, a collaborative effort with Paramount Global that aired on CBS Television and CMT Nov. 2., brought together leading artists from across genres to mobilize communities and raise critically needed funds for relief and recovery efforts to support communities across the Southeast United States that were devastated by Hurricanes Helene and Milton.

The televised fundraising event featured performances by acclaimed artists including Brittney Spencer, Chris Janson, Clay Aiken, Jonathan McReynolds, and Tyler Hubbard. The special also included appearances by numerous entertainment industry luminaries such as the Backstreet Boys, Blake Shelton, Kelsea Ballerini, Stephen Colbert, and the Zac Brown Band, alongside community heroes Mark Starling and Tank Spencer.

The Greenberg Traurig team was led by Labor & Employment Shareholder Johnine P. Barnes in Washington, D.C., and Entertainment, Media & Sports Shareholder Paul Sarker in New York.

Learn more about the benefit event on United Way’s website.

About Greenberg Traurig: Greenberg Traurig, LLP has more than 2750 attorneys in 48 locations in the United States, Europe and the Middle East, Latin America, and Asia. The firm is a 2024 BTI “Leading Edge Law Firm” for delivering on client expectations for the future and is consistently among the top firms on the Am Law Global 100 and NLJ 500. Greenberg Traurig is Mansfield Rule Certified Plus by The Diversity Lab. The firm is recognized for powering its U.S. offices with 100% renewable energy as certified by the Center for Resource Solutions Green-e® Energy program and is a member of the U.S. EPA’s Green Power Partnership Program. The firm is known for its philanthropic giving, innovation, diversity, and pro bono. Web: http://www.gtlaw.com.

Media Contact

Jacob Fischler, Greenberg Traurig, LLP, +1 202.533.2373, fischlerj@gtlaw.com, https://www.gtlaw.com/en

Twitter

View original content:https://www.prweb.com/releases/greenberg-traurig-helps-united-way-worldwide-launch-star-studded-hurricane-relief-benefit-302307415.html

SOURCE Greenberg Traurig, LLP; Greenberg Traurig, LLP

Continue Reading

Trending